{ "schemaVersion": 2, "eyebrow": "Nephrology", "title": "Urine Studies in Hyponatremia", "summary": "Use urine osmolality and spot urine sodium, obtained before therapy when feasible, to separate suppressed vasopressin states from antidiuretic water retention and to distinguish renal salt loss, extrarenal loss, SIAD, and low effective arterial volume.", "seoDescription": "Interpret urine osmolality and urine sodium in hyponatremia, including thresholds, diuretic pitfalls, saline response, and immediate management implications.", "clinicalQuestion": "How should urine osmolality and urine sodium direct etiologic classification and initial management of hyponatremia?", "specialty": "Nephrology", "audience": "U.S. physicians and medical trainees", "tags": [ "hyponatremia", "urine osmolality", "urine sodium", "SIADH", "hypovolemic hyponatremia", "hypervolemic hyponatremia", "fractional excretion of urea" ], "keyTakeaways": [ "Obtain serum osmolality, urine osmolality, and spot urine sodium before treatment when this does not delay emergency therapy; treatment rapidly changes the interpretability of urine indices. [14]", "In hypotonic hyponatremia, urine osmolality less than 100 mOsm/kg indicates suppressed antidiuretic hormone activity and directs the differential toward primary polydipsia or low-solute intake. [14][15]", "With urine osmolality greater than 100 mOsm/kg, urine sodium of 20 mEq/L or less supports extrarenal sodium loss or low effective arterial volume; a higher value raises renal salt loss, adrenal insufficiency, or SIAD after exclusions. [15][24]", "Do not diagnose SIAD from urine studies alone: require hypotonicity, clinical euvolemia, inappropriately concentrated urine, urine sodium greater than 30 mmol/L, no diuretic use, and normal thyroid and adrenal glucocorticoid function. [4]", "A sudden water diuresis after volume repletion can cause dangerous autocorrection; monitor urine output and serial sodium closely, and use desmopressin and/or D5W when correction is exceeding the intended limit. [5][17]" ], "sections": [ { "id": "obtain-and-sequence-urine-studies", "eyebrow": "Initial testing", "heading": "Order urine studies before fluids whenever the patient is stable", "intro": "Classify tonicity first, then use urine osmolality before urine sodium.", "paragraphs": [ "For any clinically meaningful hyponatremia, obtain measured serum osmolality, urine osmolality, and a spot urine sodium; obtain the urine specimen before isotonic saline, hypertonic saline, diuretics, fluid restriction, urea, or vasopressin antagonists whenever doing so does not delay resuscitation. These interventions can change urine electrolyte and osmolality patterns within hours. [14][3]", "If seizure, coma, or severe encephalopathy is attributed to hyponatremia, give 3% sodium chloride 100 to 150 mL IV over 10 to 20 minutes, repeat up to three times for ongoing seizure or inadequate neurologic improvement, and draw urine studies concurrently or immediately afterward rather than delaying treatment. A 100-mL 3% saline bolus usually raises serum sodium by 2 to 3 mmol/L; an initial increase of 4 to 6 mmol/L is intended to reduce cerebral edema and terminate most seizures. [17]", "Interpret urine indices only after confirming hypotonic hyponatremia. Iso-osmolar results can reflect pseudohyponatremia from hyperlipidemia or hyperproteinemia with indirect sodium measurement; check sodium with a direct ion-selective electrode or blood-gas analyzer when this is suspected. Hypertonic hyponatremia from glucose or another effective osmole is a translocational process, not a urine-index diagnosis. [14][10]" ], "bullets": [ "Record timing of the last loop or thiazide diuretic, IV fluid, desmopressin dose, and enteral/parenteral solute administration next to the urine results; each can alter urine sodium or urine osmolality. [1][24]", "Use the physical examination to assess effective arterial volume, but adjudicate uncertain cases with urine indices and, selectively, physiologic response to isotonic saline. [10][23]" ], "subsections": [], "table": { "caption": "Interpretive sequence for urine studies after hypotonic hyponatremia is established. [14][15][24]", "columns": [ "Result", "Physiologic interpretation", "Most useful next discriminator" ], "rows": [ [ "Urine osmolality <100 mOsm/kg", "Suppressed ADH effect; kidney is excreting dilute urine. [14][15]", "Assess water intake and dietary solute intake; prioritize primary polydipsia and low-solute intake. [14][15]" ], [ "Urine osmolality >100 mOsm/kg", "ADH-mediated water retention or impaired response to ADH is present. [14]", "Interpret spot urine sodium with volume status, renal function, and diuretic exposure. [14][24]" ], [ "Urine sodium ≤20 mEq/L", "Sodium-avid kidney, consistent with extrarenal loss or low effective arterial volume. [15]", "Differentiate true hypovolemia from heart failure, cirrhosis, and nephrotic states clinically. [9][15]" ], [ "Urine sodium >20-30 mEq/L", "Renal sodium loss or euvolemic antidiuresis; diuretics can produce a falsely high value. [15][24]", "Exclude diuretics, adrenal insufficiency, hypothyroidism, and renal dysfunction before diagnosing SIAD. [4][24]" ] ] } }, { "id": "urine-osmolality", "eyebrow": "First branch", "heading": "Use urine osmolality to identify suppressed versus active antidiuresis", "intro": "Urine osmolality is the highest-yield early urine discriminator.", "paragraphs": [ "A urine osmolality below 100 mOsm/kg in a hypotonic patient indicates dilute urine and virtual absence of clinically important ADH effect. The actionable etiologies are primary polydipsia and inadequate solute intake, including beer potomania or a low-protein, low-salt diet. In these states, identify the water and solute exposure immediately because restoration of solute or removal of the water burden can produce brisk aquaresis and rapid sodium correction. [14][15][5]", "Urine osmolality above 100 mOsm/kg is inappropriately concentrated for hypotonicity and indicates ADH-mediated water reabsorption. This result does not establish SIAD: appropriate ADH release occurs with true hypovolemia and with reduced effective arterial volume in heart failure and cirrhosis. Use urine sodium, medication history, endocrine testing, and volume assessment to determine whether the ADH signal is appropriate or inappropriate. [14][9][15]", "Urine osmolality is especially useful for anticipating correction risk. Low initial urine osmolality and inadequate antecedent solute intake are associated with polyuria and rapid autocorrection after treatment. Measure urine output frequently after initiating therapy; abrupt high-volume dilute urine is a warning that sodium may rise faster than planned. [5]" ], "bullets": [ "In older adults, diminished urinary dilution may make a urine osmolality threshold of 200 mOsm/kg more practical than 100 mOsm/kg for identifying suppressed ADH, but this is an age-specific interpretive consideration rather than a universal replacement threshold. [24]", "Do not measure plasma vasopressin routinely to classify hyponatremia; urine osmolality functions as the clinically useful surrogate for ADH effect. [9]" ], "subsections": [], "table": { "caption": "Clinical implications of urine osmolality in hypotonic hyponatremia. [14][15][5]", "columns": [ "Urine osmolality", "Likely physiology", "Immediate action" ], "rows": [ [ "<100 mOsm/kg", "Suppressed ADH; consider excess water intake or low solute intake. [14][15]", "Review daily fluid intake, alcohol intake, diet, and recent solute administration; monitor for brisk aquaresis during correction. [5][15]" ], [ "100-300 mOsm/kg", "Intermediate result; ADH may be present or absent. [9]", "Use urine sodium, medication exposure, endocrine evaluation, and clinical volume assessment rather than assigning SIAD. [9][24]" ], [ ">100 mOsm/kg", "ADH-mediated water retention. [14]", "Proceed to urine sodium and evaluate hypovolemia, low effective arterial volume, adrenal insufficiency, medications, and SIAD. [14][15][24]" ], [ ">500 mOsm/kg in SIAD", "High likelihood that fluid restriction alone will fail. [6][20]", "Plan early reassessment and consider an alternative chronic SIAD strategy if restriction is ineffective or impracticable. [6]" ] ] } }, { "id": "urine-sodium", "eyebrow": "Second branch", "heading": "Use spot urine sodium to localize sodium conservation or renal sodium loss", "intro": "Interpret urine sodium only in the context of urine osmolality, volume status, and diuretic exposure.", "paragraphs": [ "When urine osmolality is above 100 mOsm/kg, a spot urine sodium of 20 mEq/L or less indicates avid renal sodium conservation. In a clinically volume-depleted patient, this favors extrarenal losses such as diarrhea, vomiting, or third-spacing. In a patient with edema or other evidence of low effective arterial volume, it supports heart failure, cirrhosis, or nephrotic physiology rather than SIAD. [15][9]", "A urine sodium above 20 to 30 mEq/L suggests renal sodium loss or euvolemic antidiuresis. In a hypovolemic patient, consider current or recent diuretic exposure and mineralocorticoid deficiency. In an apparently euvolemic patient, exclude adrenal insufficiency, hypothyroidism, impaired renal function, and diuretics before applying SIAD criteria. [15][4][24]", "Diuretics are the major urine-sodium confounder because they increase urinary sodium and may mask sodium avidity from true hypovolemia or low effective arterial volume. If a diuretic cannot be held long enough to clarify the picture, calculate fractional excretion of urea and fractional excretion of uric acid: values below 35% and below 8%, respectively, support hypovolemia, whereas values above 55% and above 12% support SIAD in the cited older-adult framework. [24]", "A saline response can resolve persistent uncertainty when overt hypovolemia is not established and immediate correction is not otherwise required. A brisk fall in urine osmolality after a saline challenge supports hypovolemia by demonstrating suppression of volume-mediated ADH release; failure to produce this response supports normovolemic hyponatremia. Isotonic saline can worsen or minimally lower sodium in SIAD depending on urine tonicity, so use this strategy cautiously and with serial sodium and urine monitoring. [10][3]" ], "bullets": [ "Interpret urine sodium above 30 mmol/L as one SIAD criterion only when the patient has hypotonic hyponatremia, concentrated urine, apparent euvolemia, no diuretic exposure, and normal thyroid and adrenal glucocorticoid function. [4]", "In cirrhosis with suspected hypovolemic hyponatremia, diarrhea from lactulose and excessive diuresis are common correctable triggers; urine sodium helps support renal versus extrarenal sodium loss. [15]" ], "subsections": [], "table": { "caption": "Urine sodium patterns that change the etiologic branch and initial treatment. [15][24][10]", "columns": [ "Urine pattern and context", "Etiologic branch", "Next step" ], "rows": [ [ "Uosm >100 mOsm/kg; UNa ≤20 mEq/L; orthostasis, hypotension, gastrointestinal loss", "Hypovolemic hyponatremia from extrarenal sodium loss. [15]", "Restore intravascular volume with isotonic crystalloid and treat the source of loss; follow sodium and urine output for autocorrection. [7][5]" ], [ "Uosm >100 mOsm/kg; UNa >20 mEq/L; hypovolemia or diuretic exposure", "Renal sodium loss, including diuretics or mineralocorticoid deficiency. [15]", "Review and hold the causative diuretic when clinically feasible; evaluate for adrenal insufficiency. [15][4]" ], [ "Uosm >100 mOsm/kg; UNa ≤20 mEq/L; edema, heart failure, cirrhosis, nephrotic physiology", "Low effective arterial volume with hypervolemic hyponatremia. [9][15]", "Treat the underlying edematous disorder; do not interpret the low urine sodium as evidence of simple volume depletion. [9][15]" ], [ "Uosm >100 mOsm/kg; UNa >30 mmol/L; euvolemia; normal thyroid/adrenal function; no diuretics", "SIAD-compatible pattern. [4]", "Identify and reverse the trigger where possible; assess whether fluid restriction is likely to work from urine osmolality and urine electrolytes. [6][20]" ] ] } }, { "id": "siad-and-fluid-restriction", "eyebrow": "Euvolemic branch", "heading": "Use urine studies to confirm SIAD physiology and predict fluid-restriction failure", "intro": "SIAD is a diagnosis of exclusion, not a urine sodium diagnosis.", "paragraphs": [ "A SIAD-compatible profile requires an inciting factor, plasma osmolality below 275 mOsm/kg, urine osmolality above 100 mOsm/kg, urine sodium above 30 mmol/L, clinical euvolemia, no diuretic exposure, and normal thyrotropin and adrenal glucocorticoid secretion. The required exclusions are clinically decisive because adrenal insufficiency and diuretic-associated hypovolemia can generate similar urine indices but require different treatment. [4]", "For chronic SIAD, use urine concentration to decide whether fluid restriction is likely to be a low-yield strategy. Fluid restriction was effective in 59% of patients in one study; urine sodium above 130 mmol/L or urine osmolality above 500 mOsm/kg predicted lack of efficacy. A urine sodium plus urine potassium to plasma sodium ratio above 1 is also associated with nonresponse. [6][20]", "When restriction fails or is unsafe or impracticable, especially in patients with poor nutrition or cancer, move to a specific alternative rather than persisting with ineffective restriction. Urea is a studied option for SIAD, while tolvaptan produces aquaresis but carries an important overcorrection risk. In a meta-analysis of low-dose tolvaptan for SIAD, doses below 15 mg increased sodium by a mean 7.2 mmol/L in 24 hours; 7.5 mg produced a mean 7.8-mmol/L increase, with 31% overcorrection at 10 mmol/L or greater in 24 hours. [6][22]", "If tolvaptan is initiated, do not coadminister fluid restriction during early therapy because it can accentuate the correction rate. Ensure access to water and closely monitor serum sodium. Low-dose 7.5 mg, or 3.75 mg in patients judged at high risk for overcorrection, is supported by the cited meta-analysis but is below the licensed 15-mg starting dose and therefore off-label. [18][22]" ], "bullets": [ "Use urine osmolality above 500 mOsm/kg or urine sodium above 130 mmol/L as an early signal to reassess a fluid-restriction-only plan rather than waiting for prolonged nonresponse. [6]", "Avoid routine plasma vasopressin testing to establish SIAD; a high urine osmolality is the practical evidence of antidiuretic activity in the appropriate biochemical setting. [9]" ], "subsections": [], "table": { "caption": "Urine-guided decisions in chronic SIAD. [4][6][20][22]", "columns": [ "Finding", "Interpretation", "Management consequence" ], "rows": [ [ "Plasma osm <275 mOsm/kg, Uosm >100 mOsm/kg, UNa >30 mmol/L with euvolemia and exclusions met", "Meets core SIAD-compatible biochemical criteria. [4]", "Search for and correct the precipitant; choose chronic therapy according to severity and likelihood of restriction response. [4][6]" ], [ "Uosm >500 mOsm/kg or UNa >130 mmol/L", "Fluid restriction has a higher likelihood of failure. [6]", "Set an early reassessment point and consider a non-restriction strategy if sodium does not improve. [6]" ], [ "(UNa + UK)/plasma sodium >1", "Predicts poor response to fluid restriction. [20]", "Avoid relying on fluid restriction alone for durable correction. [20]" ], [ "Tolvaptan-associated brisk aquaresis", "Potential rapid sodium rise; low-dose studies still report overcorrection. [22]", "Provide free-water access, avoid concurrent fluid restriction early, and monitor sodium closely. [18][22]" ] ] } }, { "id": "monitoring-correction", "eyebrow": "Safety", "heading": "Pair urine output with serial sodium to prevent overcorrection", "intro": "The urine result can predict the next complication: abrupt water diuresis.", "paragraphs": [ "During active correction, urine output is not merely a nursing variable: rising output, especially with falling urine osmolality, indicates loss of the ADH stimulus and imminent rapid sodium correction. This is most likely after volume repletion in hypovolemic hyponatremia, when ADH suppression permits water diuresis. Check serum sodium and urine osmolality every 2 hours during a rapidly changing course. [5][17]", "For severe symptomatic chronic hyponatremia, target an initial sodium increase of 4 to 6 mmol/L to control neurologic symptoms, then avoid correction beyond 10 mmol/L in 24 hours; some expert recommendations use a more conservative 6 mmol/L-per-24-hour ceiling. The treatment goal after initial stabilization is controlled correction, not normalization of sodium on the first day. [5][7]", "If sodium is rising too quickly, use desmopressin to halt water diuresis and administer electrolyte-free water with D5W to slow or reverse correction. Desmopressin requires fluid restriction and careful supervision because its potent antidiuretic effect can cause water intoxication and hyponatremia; when used in this context, coordinate D5W, urine output, and sodium checks rather than giving either intervention without close laboratory surveillance. [17][1]", "Patients at particular risk of spontaneous overcorrection include those with low initial urine osmolality, low solute intake, and hypovolemic hyponatremia after volume repletion. Proactive and reactive desmopressin strategies have both been used for severe symptomatic hyponatremia; selection should be driven by the anticipated likelihood of brisk aquaresis and the ability to obtain frequent sodium measurements. [5]" ], "bullets": [ "Document baseline sodium, serial sodium trajectory, urine output, and urine osmolality after each major change in IV fluid, diuretic, desmopressin, or aquaretic therapy. [1][5][17]", "Treat a new sudden polyuria episode as a correction emergency until serial sodium testing shows the rate is controlled. [5][17]" ], "subsections": [], "table": { "caption": "Urine-triggered monitoring actions during active hyponatremia treatment. [5][17][1]", "columns": [ "Observed change", "Interpretation", "Action" ], "rows": [ [ "Abrupt increase in urine volume after volume repletion", "ADH suppression with emerging water diuresis and risk of autocorrection. [5]", "Increase sodium surveillance; check urine osmolality and prepare to limit further sodium rise. [5][17]" ], [ "Falling urine osmolality with ongoing sodium rise", "Loss of antidiuresis is accelerating free-water clearance. [5]", "Use D5W to slow correction and consider desmopressin to halt further aquaresis. [17][1]" ], [ "Persistent high urine osmolality in SIAD", "Continued antidiuresis; isotonic saline may fail to correct or worsen sodium depending on urine tonicity. [3]", "Avoid assuming saline responsiveness; use a cause-directed SIAD plan. [3][6]" ], [ "Sodium correction approaching 10 mmol/L in 24 hours", "Approaching the generally recommended daily correction limit. [7]", "Stop drivers of correction and actively slow or relower sodium when clinically indicated. [7][17]" ] ] } } ], "faq": [ { "question": "Can a normal or low urine sodium exclude SIAD?", "answer": "No. SIAD classification requires the complete context of hypotonicity, urine osmolality, euvolemia, urine sodium, medication exposure, renal function, and exclusion of thyroid and adrenal disorders. A low urine sodium more often redirects evaluation toward low effective arterial volume or extrarenal sodium loss. [4][15][24]" }, { "question": "When should a saline challenge be avoided as a diagnostic test?", "answer": "Do not use it when emergency hypertonic saline is indicated or when SIAD is strongly suspected without capacity for close serial sodium monitoring. Isotonic saline may increase or minimally decrease sodium in SIAD depending on urine tonicity and can worsen hyponatremia. [17][3]" } ], "references": [ { "number": 1, "title": "[PDF] 21-795 LABELING - accessdata.fda.gov", "detail": "www.accessdata.fda.gov", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2008/021795s000_Lbl.pdf", "authors": "www.accessdata.fda.gov", "host": "www.accessdata.fda.gov" }, { "number": 2, "title": "Syndrome of inappropriate antidiuretic hormone - Symptoms, diagnosis and treatment | BMJ Best Practice US", "detail": "bestpractice.bmj.com", "url": "https://bestpractice.bmj.com/topics/en-us/196", "authors": "bestpractice.bmj.com", "host": "bestpractice.bmj.com" }, { "number": 3, "title": "Urine sodium levels post-saline infusion in differentiating non ...", "detail": "www.nature.com", "url": "https://www.nature.com/articles/s41598-025-14881-5", "authors": "www.nature.com", "host": "www.nature.com" }, { "number": 4, "title": "Predictive correction of serum sodium concentration with formulas derived from the Edelman equation in patients with severe hyponatremia | Scientific Reports", "detail": "www.nature.com", "url": "https://www.nature.com/articles/s41598-023-28380-y", "authors": "www.nature.com", "host": "www.nature.com" }, { "number": 5, "title": "Safety and efficacy of proactive versus reactive administration of desmopressin in severe symptomatic hyponatremia: a randomized controlled trial | Scientific Reports", "detail": "www.nature.com", "url": "https://www.nature.com/articles/s41598-024-57657-z", "authors": "www.nature.com", "host": "www.nature.com" }, { "number": 6, "title": "Clinical efficacy of urea treatment in syndrome of inappropriate antidiuretic hormone secretion | Scientific Reports", "detail": "www.nature.com", "url": "https://www.nature.com/articles/s41598-022-14387-4", "authors": "www.nature.com", "host": "www.nature.com" }, { "number": 7, "title": "Isotonic Hyponatremia - an overview | ScienceDirect Topics", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/topics/medicine-and-dentistry/isotonic-hyponatremia", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com" }, { "number": 8, "title": "Ten common pitfalls in the evaluation of patients with hyponatremia - ScienceDirect", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/science/article/abs/pii/S0953620515004197", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com" }, { "number": 9, "title": "Hyponatremia - an overview | ScienceDirect Topics", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/hyponatremia", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com" }, { "number": 10, "title": "Hypotonic Hyponatremia - an overview | ScienceDirect Topics", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/topics/medicine-and-dentistry/hypotonic-hyponatremia", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com" }, { "number": 11, "title": "Chloride and Potassium Assessment Is a Helpful Tool for Differential ...", "detail": "academic.oup.com", "url": "https://academic.oup.com/jcem/article/108/9/2248/7076011", "authors": "academic.oup.com", "host": "academic.oup.com" }, { "number": 12, "title": "Pathophysiology, impact, and management of hyponatremia ...", "detail": "shmpublications.onlinelibrary.wiley.com", "url": "https://shmpublications.onlinelibrary.wiley.com/doi/10.1002/jhm.1932", "authors": "shmpublications.onlinelibrary.wiley.com", "host": "shmpublications.onlinelibrary.wiley.com" }, { "number": 13, "title": "Demystifying hyponatremia: A clinical guide to evaluation and ...", "detail": "aspenjournals.onlinelibrary.wiley.com", "url": "https://aspenjournals.onlinelibrary.wiley.com/doi/10.1002/ncp.10907", "authors": "aspenjournals.onlinelibrary.wiley.com", "host": "aspenjournals.onlinelibrary.wiley.com" }, { "number": 14, "title": "Severe hyponatremia: Are you monitoring the urine output? | Cleveland Clinic Journal of medicine", "detail": "www.ccjm.org", "url": "https://www.ccjm.org/content/91/4/221", "authors": "www.ccjm.org", "host": "www.ccjm.org" }, { "number": 15, "title": "Low Sodium High Stakes: Back to Basics of Hyponatremia in Cirrhosis | AASLD", "detail": "www.aasld.org", "url": "https://www.aasld.org/liver-fellow-network/core-series/back-basics/back-basics-low-sodium-high-stakes-back-basics", "authors": "www.aasld.org", "host": "www.aasld.org" }, { "number": 16, "title": "[PDF] Samsca, INN: tolvaptan - European Medicines Agency", "detail": "www.ema.europa.eu", "url": "https://www.ema.europa.eu/en/documents/assessment-report/samsca-epar-public-assessment-report_en.pdf", "authors": "www.ema.europa.eu", "host": "www.ema.europa.eu" }, { "number": 17, "title": "The Resuscitationist's Approach to Severe Hyponatremia - ACEP", "detail": "www.acep.org", "url": "https://www.acep.org/criticalcare/newsroom/newsroom-articles/september2022/the-resuscitationists-approach-to-severe-hyponatremia", "authors": "www.acep.org", "host": "www.acep.org" }, { "number": 18, "title": "[PDF] 156-08-276 Protocol Amendment 5 - ClinicalTrials.gov", "detail": "cdn.clinicaltrials.gov", "url": "https://cdn.clinicaltrials.gov/large-docs/59/NCT02012959/Prot_000.pdf", "authors": "cdn.clinicaltrials.gov", "host": "cdn.clinicaltrials.gov" }, { "number": 19, "title": "Diagnostic Approach to the Patient with Hyponatremia and ...", "detail": "applications.emro.who.int", "url": "https://applications.emro.who.int/imemrf/Iran_J_Pediatr/Iran_J_Pediatr_2007_17_1_73_76.pdf", "authors": "applications.emro.who.int", "host": "applications.emro.who.int" }, { "number": 20, "title": "Mild water restriction with or without urea for the longterm treatment of syndrome of inappropriate antidiuretic hormone secretion (SIADH): Can urine osmolality help the choice? - ScienceDirect", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/science/article/abs/pii/S0953620517303734", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com" }, { "number": 21, "title": "Hyponatremia Demystified: Integrating Physiology to Shape Clinical Practice - ScienceDirect", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/science/article/abs/pii/S2949813922000052", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com" }, { "number": 22, "title": "Low-Dose Tolvaptan for the Treatment of Syndrome of Inappropriate Antidiuretic Hormone–Associated Hyponatremia: A Systematic Review, Meta-Analysis, and Meta-Regression Analysis of Clinical Effectiveness and Safety", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/science/article/pii/S1530891X25001314", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com" }, { "number": 23, "title": "Hypoosmolarity - an overview | ScienceDirect Topics", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/topics/medicine-and-dentistry/hypoosmolarity", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com" }, { "number": 24, "title": "Special considerations of hyponatremia in the elderly patient", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/science/article/abs/pii/S1521690X25000739", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com" } ], "editorialNote": "Prepared from cited clinical literature using Astra's research workflow. Verify recommendations against current guidance and patient-specific factors.", "citations": [ { "number": 1, "title": "[PDF] 21-795 LABELING - accessdata.fda.gov", "detail": "www.accessdata.fda.gov", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2008/021795s000_Lbl.pdf", "authors": "www.accessdata.fda.gov", "host": "www.accessdata.fda.gov", "snippet": "WARNINGS 1. Very rare cases of hyponatremia have been reported from world-wide postmarketing experience in patients treated with desmopressin acetate. Desmopressin acetate is a potent antidiuretic which, when administered, may lead to water intoxication and/or hyponatremia.\nUnless properly diagnosed", "score": 0.32091758 }, { "number": 2, "title": "Syndrome of inappropriate antidiuretic hormone - Symptoms, diagnosis and treatment | BMJ Best Practice US", "detail": "bestpractice.bmj.com", "url": "https://bestpractice.bmj.com/topics/en-us/196", "authors": "bestpractice.bmj.com", "host": "bestpractice.bmj.com", "snippet": "###### Disclosures\n\nPeer reviewer affiliations and disclosures pertain to the time of the review.\n\n### References\n\n#### Key articles\n\nGross P. Clinical management of SIADH. Ther Adv Endocrinol Metab. 2012 Apr;3(2):61-73.Full textAbstract\n\nSpasovski G, Vanholder R, Allolio B, et al. Clinical practice", "score": 0.5968332 }, { "number": 3, "title": "Urine sodium levels post-saline infusion in differentiating non ...", "detail": "www.nature.com", "url": "https://www.nature.com/articles/s41598-025-14881-5", "authors": "www.nature.com", "host": "www.nature.com", "snippet": "To avoid confounding the diagnostic utility of urine and serum biochemical responses, no active treatment for hyponatremia (e.g., fluid restriction, oral salt tablets, urea, or vaptans) was administered during the initial evaluation and saline infusion phase. Therapeutic interventions were initiated", "score": 0.65359193 }, { "number": 4, "title": "Predictive correction of serum sodium concentration with formulas derived from the Edelman equation in patients with severe hyponatremia | Scientific Reports", "detail": "www.nature.com", "url": "https://www.nature.com/articles/s41598-023-28380-y", "authors": "www.nature.com", "host": "www.nature.com", "snippet": "sex, solid tumor, low CCI, low urine [Na], and low urine osmolality were not significantly associated with the appropriate correction of hyponatremia23 score. Clin. J. Am. Soc. Nephrol. 14, 975–982 (2019).\"),24.\"),25.\"). In addition, the administration of hypertonic saline continuous infusion was al", "score": 0.49875546 }, { "number": 5, "title": "Safety and efficacy of proactive versus reactive administration of desmopressin in severe symptomatic hyponatremia: a randomized controlled trial | Scientific Reports", "detail": "www.nature.com", "url": "https://www.nature.com/articles/s41598-024-57657-z", "authors": "www.nature.com", "host": "www.nature.com", "snippet": "As recognized, overcorrection in hyponatremia management depends on crucial factors, including the rapid sodium level increase post-treatment and patients' susceptibility to serum sodium rise due to autocorrection, like ADH suppression after volume repletion in hypovolemic situations, causing signif", "score": 0.46978843 }, { "number": 6, "title": "Clinical efficacy of urea treatment in syndrome of inappropriate antidiuretic hormone secretion | Scientific Reports", "detail": "www.nature.com", "url": "https://www.nature.com/articles/s41598-022-14387-4", "authors": "www.nature.com", "host": "www.nature.com", "snippet": "Fluid restriction has proved to be effective in 59% of the patients with SIADH; possible predictors of lack of efficacy are urine sodium concentration > 130 mmoL/L and urine osmolality > 500 mOsm/kg28, 609–617. \n \n \n (2016).\"). This indicates that it", "score": 0.35999444 }, { "number": 7, "title": "Isotonic Hyponatremia - an overview | ScienceDirect Topics", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/topics/medicine-and-dentistry/isotonic-hyponatremia", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com", "snippet": "should intervene. Per the United States guidelines, if the limit is reached in a patient whose baseline sodium was greater than 120 mmol/L, then correction is likely unnecessary. If the baseline was less than 120 mmol/L, then the clinician ought to relower the sodium. The European guidelines suggest", "score": 0.6999322 }, { "number": 8, "title": "Ten common pitfalls in the evaluation of patients with hyponatremia - ScienceDirect", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/science/article/abs/pii/S0953620515004197", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com", "snippet": "### Am J Kidney Dis\n\n### Clinical assessment of extracellular fluid volume in hyponatremia\n\n### Am J Med\n\n### Combined fractional excretion of sodium and urea better predicts response to saline in hyponatremia than do usual clinical and biochemical parameters\n\n### Am J Med\n\n### The syndrome of inapp", "score": 0.57637566 }, { "number": 9, "title": "Hyponatremia - an overview | ScienceDirect Topics", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/hyponatremia", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com", "snippet": "The diagnostic criteria for SIADH are summarized in Figure 8.10. Plasma vasopressin may be in the “normal” range (up to 10 ng/l), but this is inappropriate given the hypo-osmolar state. In clinical practice, the measurement of plasma vasopressin is rarely needed as the urinary osmolality provides an", "score": 0.52057004 }, { "number": 10, "title": "Hypotonic Hyponatremia - an overview | ScienceDirect Topics", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/topics/medicine-and-dentistry/hypotonic-hyponatremia", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com", "snippet": "Hyponatremia is defined as a serum sodium level lower than 135 mEq/L, but it may be asymptomatic at levels less than 125 mEq/L in chronic, slowly developing cases. Hypotonicity is always associated with hyponatremia, but hyponatremia may be isotonic (e.g., as an artifact in hyperlipidemia or hyperpr", "score": 0.50388235 }, { "number": 11, "title": "Chloride and Potassium Assessment Is a Helpful Tool for Differential ...", "detail": "academic.oup.com", "url": "https://academic.oup.com/jcem/article/108/9/2248/7076011", "authors": "academic.oup.com", "host": "academic.oup.com", "snippet": "The European Clinical Practice Guidelines (6) for diagnosis and management of hypotonic hyponatremia propose a diagnostic algorithm based on urine indices (", "score": 0.5158888 }, { "number": 12, "title": "Pathophysiology, impact, and management of hyponatremia ...", "detail": "shmpublications.onlinelibrary.wiley.com", "url": "https://shmpublications.onlinelibrary.wiley.com/doi/10.1002/jhm.1932", "authors": "shmpublications.onlinelibrary.wiley.com", "host": "shmpublications.onlinelibrary.wiley.com", "snippet": "In addition, urine sodium and urine osmolality should be checked, as they can often help confirm the assessment of the patient's volume status and assist in", "score": 0.64719695 }, { "number": 13, "title": "Demystifying hyponatremia: A clinical guide to evaluation and ...", "detail": "aspenjournals.onlinelibrary.wiley.com", "url": "https://aspenjournals.onlinelibrary.wiley.com/doi/10.1002/ncp.10907", "authors": "aspenjournals.onlinelibrary.wiley.com", "host": "aspenjournals.onlinelibrary.wiley.com", "snippet": "Evaluation of hyponatremia relies on clinical assessment and estimation of serum sodium, urine electrolytes, and serum and urine osmolality", "score": 0.48908922 }, { "number": 14, "title": "Severe hyponatremia: Are you monitoring the urine output? | Cleveland Clinic Journal of medicine", "detail": "www.ccjm.org", "url": "https://www.ccjm.org/content/91/4/221", "authors": "www.ccjm.org", "host": "www.ccjm.org", "snippet": "Urine osmolality can range from approximately 50 mOsm/kg to 1,200 mOsm/kg. A urine osmolality higher than 100 mOsm/kg implies ADH-mediated free water reabsorption and would be considered abnormally concentrated urine in a hyponatremic state.8 A urine osmolality less than 100 mOsm/kg denotes a dilute", "score": 0.63234437 }, { "number": 15, "title": "Low Sodium High Stakes: Back to Basics of Hyponatremia in Cirrhosis | AASLD", "detail": "www.aasld.org", "url": "https://www.aasld.org/liver-fellow-network/core-series/back-basics/back-basics-low-sodium-high-stakes-back-basics", "authors": "www.aasld.org", "host": "www.aasld.org", "snippet": "Urine studies including urine osmolality and urine sodium further refine the differential. Urine osmolality <100 mOsm/kg indicates appropriate free water excretion and lack of ADH activity, as seen in primary polydipsia or poor solute intake (“tea and toast” diet). Urine osmolality in hypotonic hypo", "score": 0.61834323 }, { "number": 16, "title": "[PDF] Samsca, INN: tolvaptan - European Medicines Agency", "detail": "www.ema.europa.eu", "url": "https://www.ema.europa.eu/en/documents/assessment-report/samsca-epar-public-assessment-report_en.pdf", "authors": "www.ema.europa.eu", "host": "www.ema.europa.eu", "snippet": "(mean increase of 5.73 vs. 1.00 mEq/L at the last visit respectively). Mean urine sodium concentrations decreased (by 1.33 to 20.40 mEq/L) in the tolvaptan group while they increased (by 9.67 to 34.44 mEq/L) in the fluid restriction group. Urine potassium levels showed Page 38 of 49 similar changes.", "score": 0.57780564 }, { "number": 17, "title": "The Resuscitationist's Approach to Severe Hyponatremia - ACEP", "detail": "www.acep.org", "url": "https://www.acep.org/criticalcare/newsroom/newsroom-articles/september2022/the-resuscitationists-approach-to-severe-hyponatremia", "authors": "www.acep.org", "host": "www.acep.org", "snippet": "and urine osmolarity should be assessed every 2 hours. If the serum sodium is still rising, give D5W to further slow correction.1,2 Maintain sodium correction to 0.5mmol/L/hr or lower sodium by this same rate to the initial correction goal of 4-8mmol/L in 24 hours.3 For the average 70kg person, a ra", "score": 0.5677694 }, { "number": 18, "title": "[PDF] 156-08-276 Protocol Amendment 5 - ClinicalTrials.gov", "detail": "cdn.clinicaltrials.gov", "url": "https://cdn.clinicaltrials.gov/large-docs/59/NCT02012959/Prot_000.pdf", "authors": "cdn.clinicaltrials.gov", "host": "cdn.clinicaltrials.gov", "snippet": "6.2 Pharmacodynamic Analysis Urine volume will be summarized by 6-hour intervals using descriptive statistics. Fluid intake and the calculated value of fluid balance will be summarized for each 6-hour period and for the 24-hour daily interval on Days 1 and 2 in Treatment Phase A using descriptive st", "score": 0.43828082 }, { "number": 19, "title": "Diagnostic Approach to the Patient with Hyponatremia and ...", "detail": "applications.emro.who.int", "url": "https://applications.emro.who.int/imemrf/Iran_J_Pediatr/Iran_J_Pediatr_2007_17_1_73_76.pdf", "authors": "applications.emro.who.int", "host": "applications.emro.who.int", "snippet": "No 1, Mar 2007 Downloaded from http://journals.tums.ac.ir/ on Sunday, July 15, 2012 74 Hyponatremia: diagnostic approach & causes, F Assadi depletion (e.g., hypotension, urine sodium >10 mEq/L). Massive water ingestion: If diluting ability is intact, and renal function is normal, the urine Downloade", "score": 0.98402 }, { "number": 20, "title": "Mild water restriction with or without urea for the longterm treatment of syndrome of inappropriate antidiuretic hormone secretion (SIADH): Can urine osmolality help the choice? - ScienceDirect", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/science/article/abs/pii/S0953620517303734", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com", "snippet": "### Semin Nephrol\n\n### Cerebral salt wasting syndrome: review\n\n### Eur J Intern Med\n\n### Urea minimizes brain complications following rapid correction of chronic hyponatremia compared with vasopressin antagonist or hypertonic saline\n\n### Kidney Int\n\n### Prevalence of hyponatremia and association wit", "score": 0.47621483 }, { "number": 21, "title": "Hyponatremia Demystified: Integrating Physiology to Shape Clinical Practice - ScienceDirect", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/science/article/abs/pii/S2949813922000052", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com", "snippet": "### The treatment of hyponatremia\n\n### Semin Nephrol\n\n### The urine/plasma electrolyte ratio: a predictive guide to water restriction\n\n### Am J Med Sci\n\n### Efficacy of furosemide, oral sodium chloride, and fluid restriction for treatment of syndrome of inappropriate antidiuresis (SIAD): an open-lab", "score": 0.32088566 }, { "number": 22, "title": "Low-Dose Tolvaptan for the Treatment of Syndrome of Inappropriate Antidiuretic Hormone–Associated Hyponatremia: A Systematic Review, Meta-Analysis, and Meta-Regression Analysis of Clinical Effectiveness and Safety", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/science/article/pii/S1530891X25001314", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com", "snippet": "### Results\n\nFrom 968 identified studies, 18 met inclusion criteria, comprising 495 patients. Initial doses below 15 mg increased the serum sodium level by 7.2 mmol/L (95% CI, 6.0-8.4) within 24 hours. In the 7.5-mg subgroup (n = 286), the mean increase was 7.8 mmol/L (95% CI, 6.2-9.4). The overcorr", "score": 0.31217125 }, { "number": 23, "title": "Hypoosmolarity - an overview | ScienceDirect Topics", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/topics/medicine-and-dentistry/hypoosmolarity", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com", "snippet": "Image 4: Fig. 1\n\nSign in to download hi-res image\n\nFig. 1. Diagnostic algorithm for hyponatremia.\n\n In primary polydipsia, water intake exceeds the renal excretory capacity for water. An inhibition of ADH occurs, which is why urine osmolality is very low.\n\n In chronic kidney disease there is initial", "score": 0.6783488 }, { "number": 24, "title": "Special considerations of hyponatremia in the elderly patient", "detail": "www.sciencedirect.com", "url": "https://www.sciencedirect.com/science/article/abs/pii/S1521690X25000739", "authors": "www.sciencedirect.com", "host": "www.sciencedirect.com", "snippet": "failure, cirrhosis), or inappropriate such as in SIAD , . Unfortunately, measuring AVP directly or its stable surrogate marker copeptin has not proven helpful in this differentiation , . Accordingly, it is generally advised to measure urine sodium as a next step. Urine sodium reflects the renin-angi", "score": 0.56258565 } ], "publishedAt": "2026-09-15T21:45:49.291059+00:00", "updatedAt": "2026-09-15T21:45:49.291059+00:00", "readingMinutes": 7, "slug": "urine-studies-in-hyponatremia" }